Northern Exposure PR
We are the leading public relations company serving the life science, pharmaceutical and technology industries.Northern Exposure is the leading public relations company serving the life science, pharmaceutical and technology industries.
Twenty years experience maximising clients’ media exposure and advising on subjects from press handling, marketing strategy and reputation management
Northern Exposure Public Relations is uniquely skilled in assisting clients in all public relations requirements
Meet Our Team
Richard Kerns
Managing Director
Richard has twenty five years’ experience working with life science companies and organisations around the globe, both independently and within larger agencies.
Edward Dutton
Vice President
Ed has over fifteen years experience of working within the pharmaceutical industry, both as a laboratory chemist and in sales and marketing roles within contract research organisations, contract manufacturers and technology based companies.
Sarah Houlton
Technical Consultant in Residence
Sarah has a degree and PhD in chemistry from Imperial College London, and worked as a drug discovery chemist in the pharmaceutical industry. As a science journalist, she has been writing about the pharmaceutical, biotech and chemical industries for more than twenty years.
Our Services
NEPR can assist clients in numerous manners, either on a retained agency basis or through project work around events. Activities include:
Planning & research, web content creation, media relations, technical articles, thought leadership articles, trade show and event management and support, social media, product launches, crisis management & more.
Contact us today to find out how we can assist you
Our Clients
Client News
30/01/2018 Cambrex Expands Process Research and Development Capabilities Across North America
28/02/2018 Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility
12/04/2018 Catalent Completes $5.5 Million Expansion of Clinical Storage at Philadelphia Facility
17/04/2018 SGS Strengthens Belgian Clinical Pharmacology Unit with Appointment of New Medical Director
17/04/2018 Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility
24/04/2018 SGS H3N2 Challenge Virus Wins the Medicine Maker 2017 Innovation Awards
14/05/2018 Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars
15/05/2018 Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility
17/05/2018 Catalent Completes $5.5 Million Phased Clinical Storage Expansion at Kansas City Campus
31/05/2018 Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility
31/05/2018 Catalent Biologics Supports InterveXion on New Treatment for Methamphetamine Users
05/06/2018 SGS Quality, Expertise & Reliability Recognized at 2018 CRO Leadership Awards
12/06/2018 Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site
13/06/2018 Catalent Appoints Paul Hegwood as New President of Clinical Supply Services
03/07/2018 Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.
14/08/2018 Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.
28/08/2018 SGS to Open New Biopharmaceutical Testing Laboratory in Geneva
10/09/2018 IDEXX Pseudalert Test Accepted as Global ISO Standard
11/09/2018 New SGS Biopharmaceutical Testing Capabilities in Illinois
12/09/2018 Cambrex Completes Acquisition of Halo Pharma
04/10/2018 Catalent Invests $7.3 Million at its Aprilia, Italy Facility
08/10/2018 Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
Upcoming Events
NEPR will be attending the following events:
CPhI Worldwide
October 9 -11, 2018
IFEMA, Feria de Madrid, Spain
about 4 months ago | @NrthnExposurePR